Sponsors (3)
The bill aims to make organ and tissue donation safer by developing and piloting TB screening and standardized recommendations, but it imposes costs, operational burdens, and possible regulatory delays on health systems and taxpayers.
Transplant recipients would face a lower risk of tuberculosis (TB) transmission if a validated cadaver-tissue TB test is developed and implemented, reducing post‑transplant infections and related harms.
Hospitals, tissue banks, and organ donation systems would gain standardized donor screening recommendations that improve overall safety and public confidence in donation programs.
Researchers and HHS would better identify TB detection research gaps and pilot tests across diverse populations, guiding targeted funding and future improvements in donor screening methods.
Hospitals, tissue banks, and organ procurement organizations would face new operational burdens and costs to adopt recommended testing and specimen protocols, potentially straining budgets and workflows.
Hospitals and donation systems could experience delays or added steps from recommended regulatory changes, increasing turnaround time for donation processes and possibly reducing organ/tissue availability.
Taxpayers could incur additional costs if HHS uses appropriated funds to support studies and follow-up activities between FY2027 and FY2031.
Based on analysis of 2 sections of legislative text.
Requires HHS to study feasibility of standardized TB testing in human cadaver tissue and report findings and recommendations to Congress within three years.
Official title: To direct the Secretary of Health and Human Services to conduct a study on the feasibility of developing an accurate and reliable standardized test for detecting tuberculosis in tissue from a human cadaver, and for other purposes.
Introduced June 30, 2026 by John Moolenaar · Last progress June 30, 2026
Requires the Department of Health and Human Services to carry out a comprehensive, interagency study on whether an accurate, reliable standardized test or testing strategy can detect tuberculosis in human cadaver tissue to improve donor screening and transplant safety. The study must be completed within two years, done with relevant federal agencies and stakeholders, and produce a report to Congress within three years with findings and recommendations.